Astrazeneca plc ADR (NASDAQ:AZN) currently has a daily average trading volume of 6.09M but it saw 4393517 shares traded in last market. With a market cap of 216.10B USD, the company’s current market price of $69.68 came falling about -0.34 while comparing to the previous closing price of $69.92. In past 52 weeks, the stock remained buoying in the range of price level as high as $87.68 and as low as $61.24.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Exane BNP Paribas which initiated the stock as “Outperform” in its note to investors issued on April 15, 2025, recommending a price target of $75 for it.
Over the week, AZN’s stock price is moving 5.21% up while it is 2.67% when we observe its performance for the past one month. Year-to-date it is 6.35% up and over the past year, the stock is showing a downside performance of -9.39%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 1.14 while estimate for next year EPS is 4.51. In next quarter, company is expected to be making quarterly sales of $14.57B as analysts are expecting the sales for current fiscal year at $57.81B and seeing the company making $61.17B in sales next year. Moreover, analysts are in estimates of $14.08B for current-quarter revenue.
Currently, Astrazeneca plc ADR’s total number of outstanding shares is 3.10B with 0.00% of that held by the insiders while 17.20% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 11.28% and return on equity (ROE) at 19.81%. It has a price to earnings ratio (P/E ratio) of 27.99 while having a 13.70 of forward P/E ratio. Stock’s beta reads 0.38. Stock has a price to book (P/B) ratio of 5.27 while price to sale or P/S ratio amounts to 3.93. Its return on asset (ROA) is 7.45% on average.
